pillbase.ru

Vyepti

Active substance: eptinezumab

INJECTION · EPTINEZUMAB 100 mg/mL

United StatesActive

Marketing holder: Lundbeck Pharmaceuticals LLC

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 1
  • Vyepti
    Eptinezumab
    EMEA/H/C/005287
    H. Lundbeck A/S
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1209b-9acd-7a92-bf97-065f56309198;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
67386-130
Registration status
Active
Dispensing
Prescription only
Route
INTRAVENOUS
Sources
  • product · openFDA NDC · 67386-130 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 67386-130 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 67386-130 · Verified 2026-10-09 · open in source